CR Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
pos +2.15
Today's Range: 187.15 - 190.66 | BCR Avg Daily Volume: 558,000
Last Update: 12/01/15 - 4:05 PM EST
Volume: 457,094
YTD Performance: 12.12%
Open: $188.45
Previous Close: $186.82
52 Week Range: $163.08 - $202.47
Oustanding Shares: 73,886,090
Market Cap: 13,844,036,683
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 12 12 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.67 2.67 2.67 2.67
Latest Dividend: 0.24
Latest Dividend Yield: 0.51%
Dividend Ex-Date: 10/22/15
Price Earnings Ratio: 109.57
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
109.57 108.70 32.66
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.39% 11.63% 88.69%
Revenue 9.00 0.15 0.05
Net Income -57.30 -0.10 -0.03
EPS -55.30 0.02 0.01
Earnings for BCR:
Revenue 3.32B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $2.41 $2.30 $9.06 $9.90
Number of Analysts 14 8 15 15
High Estimate $2.42 $2.38 $9.07 $10.05
Low Estimate $2.40 $2.24 $9.04 $9.61
Prior Year $2.29 $2.10 $8.40 $9.06
Growth Rate (Year over Year) 5.24% 9.40% 7.84% 9.34%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
With no top in sight, we remain bulls on this name.
Aug 27, 2015 | 6:51 AM EDT
Coverage of BCR was started with a Sector Weight rating, Keybanc said. Stock is already pricing in a better sales outlook. 
The last two days have changed the entire structure of the markets.
There are some good buying ideas among these stocks.
Apr 24, 2015 | 8:14 AM EDT
BCR was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $200 price target. See higher growth from the drug eluting ba...
Traders should be looking for shorting opportunities.
Jan 20, 2015 | 7:30 AM EST
BCR was upgraded from Underweight to Neutral, JP Morgan said. Lutonix and drug-coated ballons could exceed expectations. 
Jan 05, 2015 | 7:51 AM EST
BCR was downgraded from Neutral to Underweight, JP Morgan said. Valuation call, based on a $162 price target. 
Jan 05, 2015 | 6:43 AM EST
BCR was upgraded to Equal-weight from Underweight, Morgan Stanley said. $187 price target. Company has significant earnings flexibility...

Columnist Conversations

I just wanted to post a quick chart after my 3 day mini-vacation. This daily chart that has been in a buy mod...
Markets having nice start to December. Seeing some movement in my healthcare/biotech portfolio today in the f...
The Dollar Index (DXY) hit a one-tick, 2015 new high at 100.31 yesterday. (11/30), but has turned a touch lowe...
With the markets having rallied so strongly off their August lows, are there any bears left? Are there any sca...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.